Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,898,935
+$516,466 QoQ
Shares Held
214,577
+12.1% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $50,237,325 across 12 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
625,048 | $23,589,311 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
529,503 | $7,677,793 | |
| 3 | HROW |
Harrow, Inc.
|
158,110 | $5,574,958 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,743 | $3,133,136 | |
| 5 | VTRS |
Viatris Inc
This page
|
214,577 | $2,898,935 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
88,379 | $2,661,975 | |
| 7 | CRON |
Cronos Group Inc.
|
601,859 | $1,510,666 | |
| 8 | ETON |
Eton Pharmaceuticals, Inc.
|
55,605 | $1,372,331 |
All Filings in VTRS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,898,935 | 214,577 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,382,469 | 191,363 | Shares | Other | 2026-02-17 | |
| 2023-03-31 | $153,920 | 16,000 | Shares | Other | 2023-05-15 | |
| 2020-12-31 | $257,806 | 13,757 | Shares | Other | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||